IART: Integra LifeSciences Holdings Corp.
About
Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. It operates under the Codman Specialty Surgical (CSS) and Tissue Technologies (TT) segments. The CSS segment includes technologies and instrumentation used for neurosurgery, neurocritical care, and otolaryngology. The TT segment focuses on complex wound surgery, surgical reconstruction, and peripheral nerve repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.
Key Details
Market Cap
$1.77B
P/E Ratio
-256.79
1Y Stock Return
-40.82%
1Y Revenue Growth
1.45%
Dividend Yield
0.00%
Price to Book
1.2
Strategies that include IART
Stock's related to IART
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| ATSG | 49.61% | $1.44B | +39.23% | 0.00% |
| GSAT | 41.88% | $3.29B | +19.18% | 0.00% |
| KFRC | 40.76% | $1.10B | -8.71% | 0.66% |
| ONL | 37.35% | $218.76M | -20.85% | 10.31% |
| ZEUS | 37.19% | $436.06M | -28.26% | 1.47% |
| NGNE | 36.69% | $223.88M | +32.95% | 0.00% |
| AROW | 36.24% | $546.36M | +34.05% | 4.19% |
| AORT | 36.21% | $1.13B | +69.69% | 0.00% |
| GMRE | 36.03% | $579.18M | -10.99% | 9.69% |
| STEL | 35.50% | $1.58B | +26.76% | 1.77% |
| VBTX | 35.32% | $1.58B | +53.68% | 2.75% |
| TILE | 35.25% | $1.45B | +150.00% | 0.16% |
| CLBK | 35.05% | $1.89B | +4.93% | 0.00% |
| ORGO | 34.84% | $540.91M | +59.38% | 0.00% |
| AMR | 34.55% | $3.14B | -8.29% | 0.21% |
| STHO | 34.48% | $150.51M | -5.99% | 0.00% |
| HLIO | 34.32% | $1.68B | +26.81% | 0.72% |
| HAFC | 34.08% | $767.29M | +55.13% | 3.93% |
| CLDT | 34.03% | $425.53M | -12.03% | 3.24% |
| PFC | 34.03% | $990.65M | +38.69% | 4.50% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| SMC | -0.01% | $383.35M | +97.26% | 0.00% |
| ZCMD | 0.02% | $2.80M | -88.67% | 0.00% |
| LLY | -0.02% | $692.74B | +23.14% | 0.71% |
| ASC | 0.03% | $517.16M | -7.62% | 8.45% |
| XBIT | 0.03% | $203.32M | +87.36% | 0.00% |
| BMA | 0.04% | $5.08B | +232.03% | 6.53% |
| VIRT | -0.04% | $3.17B | +110.38% | 2.60% |
| ROOT | 0.07% | $1.53B | +972.93% | 0.00% |
| COR | 0.07% | $47.48B | +21.20% | 0.86% |
| GALT | -0.09% | $172.91M | +41.28% | 0.00% |
| GAN | 0.12% | $83.39M | +21.19% | 0.00% |
| UUU | 0.12% | $4.97M | -41.89% | 0.00% |
| SU | -0.14% | $52.05B | +23.58% | 3.92% |
| NEUE | -0.15% | $40.93M | -34.13% | 0.00% |
| LXFR | 0.19% | $387.04M | +72.02% | 3.60% |
| IMAX | 0.22% | $1.31B | +51.92% | 0.00% |
| TRIN | 0.22% | $842.35M | -3.18% | 14.19% |
| CLLS | 0.22% | $141.30M | -30.99% | 0.00% |
| AGX | 0.23% | $2.01B | +224.91% | 0.85% |
| EDSA | 0.26% | $7.11M | -21.79% | 0.00% |
ETF's related to IART
News
Yahoo
According to a health economic evaluation, Integra's DuraSeal Dural Sealant is revealed to reduce healthcare costs.
Yahoo
The health economic analysis, conducted in five European countries, shows that hospitals can reduce costs of cerebrospinal fluid leaks after posterior cranial fossa surgeries by using DuraSeal dural sealant instead of fibrin gluePRINCETON, N.J., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced the publication of a new economic study, “PEG hydrogel sealant versus fibrin glue in posterior fossa
Finnhub
The following is an excerpt from a Q&A with Dan Cooper about how he followed his father's footsteps into the military, how his experiences helped shape his career in Quality and how he is paying it...
Yahoo
Citi raised the firm’s price target on Integra LifeSciences (IART) to $22 from $16 and keeps a Sell rating on the shares. The company reported a somewhat better than expected Q3, the analyst tells investors in a research note. The firm says likely the most important part of the Q3 call was the appointment of Mojdeh Poul as new CEO effective January, “bringing fresh eyes to the organization.” Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try
Yahoo
IART is optimistic about the fact that the shipping holds have largely been resolved within the third quarter.
Yahoo
Integra LifeSciences Holdings ( NASDAQ:IART ) Third Quarter 2024 Results Key Financial Results Revenue: US$380.8m (flat...
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.